Perspective Therapeutics
CATX
27 hedge funds and large institutions have $5.57M invested in Perspective Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0.37% less ownership
Funds ownership: 6.86% → 6.49% (-0.37%)
4% less funds holding
Funds holding: 28 → 27 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
46% less capital inflows, than outflows
Capital inflows: $355K | Capital outflows: $652K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$280K |
| 2 |
CAG
Crestwood Advisors Group
Boston,
Massachusetts
|
+$22.8K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$17.8K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$14.5K |
| 5 |
JIC
Joel Isaacson & Co
New York
|
+$7.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$201K |
| 2 |
Millennium Management
New York
|
-$109K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$97.9K |
| 4 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
-$69.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$45K |
CATX Hedge Fund Activity: Q1 2015 in Review
27 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2015, worth a combined $5.57M — up 1.5% from $5.49M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CATX and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $280K. The largest seller was Morgan Stanley, cutting an estimated $201K.
- 27 institutional investors held Perspective Therapeutics (CATX) as of Q1 2015, down from 28 in Q4 2014.
- Funds reported $5.57M of Perspective Therapeutics stock for Q1 2015, up 1.5% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q1 2015 and 5 closed out, a net change of -1 holder.
- The largest Perspective Therapeutics buyer in Q1 2015 was BlackRock Institutional Trust, an estimated $280K added.
- The largest Perspective Therapeutics seller in Q1 2015 was Morgan Stanley, an estimated $201K sold.
Based on aggregated 13F filings for Q1 2015.